Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

65267 Press Releases
DateTitleCompany
27 Oct 11 Questcor Teams with Child Neurology Foundation (CNF) to Continue Funding Infantile Spasms Scientific Research NEXT LEVEL COMMUNICATIONS - CG,
Published by
PR Newswire
27 Oct 11 MEDfx Demonstrates Potential of Connected Healthcare by Enabling Military and Civilian Medical Professionals to Securely Access Records, Improve Care Coordination SS PUBLIC RELATIONS INC,
Published by
PR Newswire
27 Oct 11 Rite Aid Reports 2.9 Percent Same Store Sales Increase for October Rite Aid Corporation,
Published by
Business Wire
27 Oct 11 Bristol-Myers Squibb Delivers Strong Third Quarter with Important Clinical Data, Solid Operating Results and Continued Focus on Business Development Bristol-Myers Squibb Company,
Published by
Business Wire
27 Oct 11 P&G Announces Strong First Quarter Sales Growth; EPS in Line with Expectations The Procter & Gamble Company,
Published by
Business Wire
27 Oct 11 Celgene Reports Record Third Quarter 2011 Operating and Financial Results Celgene Corporation,
Published by
Business Wire
27 Oct 11 Sucampo Appoints Cary J. Claiborne as Chief Financial Officer Sucampo Pharmaceuticals Inc.,
Published by
Business Wire
27 Oct 11 Arrowhead Research Appoints Bruce Given M.D. Chief Operating Officer Arrowhead Research Corporation,
Published by
Business Wire
27 Oct 11 Curis Reports Third Quarter 2011 Financial Results Curis Inc.,
Published by
Business Wire
27 Oct 11 SwabCap Is Focus of NACHRI Pediatric Conference Award Excelsior Medical Corporation,
Published by
Business Wire
27 Oct 11 Chromatin, Inc. Appoints Henry Hirvela as Chief Financial Officer Chromatin Inc.,
Published by
Business Wire
27 Oct 11 Selecta Announces $47.25 Million Financing to Broaden R&D Capabilities and Accelerate Pipeline of Vaccines and Immunotherapies Selecta Biosciences Inc.,
Published by
Business Wire
27 Oct 11 Biogen Idec and Portola Pharmaceuticals Announce Global Collaboration for Oral Syk Inhibitor Program Targeting Autoimmune and Inflammatory Diseases Biogen Idec and Portola Pharmaceuticals,
Published by
Business Wire
27 Oct 11 Bruker Reports Financial Results for the Third Quarter of 2011 Bruker Corporation,
Published by
Business Wire
27 Oct 11 Incyte Reports Third Quarter 2011 Financial Results and Provides Update on Key Clinical Programs Incyte Corporation,
Published by
Business Wire
27 Oct 11 SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2011 FINANCIAL RESULTS Senomyx Inc.,
Published by
Business Wire
27 Oct 11 RUSNANO invests in Selecta Biosciences and BIND Biosciences to develop and commercialize vaccines and cancer drugs through expanded operations in Russia BIND Biosciences Inc.,
Published by
Business Wire
27 Oct 11 BIND Announces New $47.25 Million Financing To Accelerate Multi-Product Pipeline BIND Biosciences,
Published by
Business Wire
27 Oct 11 Biopharmaceutical Contract Manufacturing Study Shows Improving Industry Growth Prospects HighTech Business Decisions,
Published by
Business Wire
27 Oct 11 Ironwood and Forest to Present Linaclotide Results from Phase 2B and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation Forest Laboratories Inc. & Ironwood Pharmaceuticals Inc.,
Published by
Business Wire
27 Oct 11 Sucampo Announces Third Quarter 2011 Financial Results and Operating Highlights Teleconference and Webcast Sucampo Pharmaceuticals Inc.,
Published by
Business Wire
27 Oct 11 Infinity Announces the Date of Its Third Quarter 2011 Financial Results Conference Call and Webcast Infinity Pharmaceuticals Inc.,
Published by
Business Wire
27 Oct 11 VetNostic Laboratories® Announces New Testing for Dog Breeds ERELEASES,
Published by
PR Newswire
27 Oct 11 Department of Defense Selects Rethink Autism Educational Platform for Military Base Schools Worldwide ERELEASES,
Published by
PR Newswire
27 Oct 11 Breast Reconstruction With Your Belly Fat Using Brava - TWO FOR ONE DEAL ERELEASES,
Published by
PR Newswire
27 Oct 11 Ipsen’s first nine months of 2011 sales Ipsen,
Published by
IPSEN
27 Oct 11 Research and Markets: The Global Antibiotic Manufacturers Industry Report Research and Markets,
Published by
Business Wire
27 Oct 11 ICON Reports Q3 revenue growth of 7% to $241 million and net new business of $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209) ICON plc,
Published by
Business Wire
27 Oct 11 Pfizer Receives European Approval to Extend Use of Prevenar 13 to Adults 50 Years and Older for the Prevention of Invasive Pneumococcal Disease Pfizer Inc.,
Published by
Business Wire
27 Oct 11 Columbia Laboratories to Discuss Third Quarter 2011 Financial Results on November 3, 2011, Conference Call Columbia Laboratories Inc.,
Published by
Business Wire
Advertising